942215-76-1 Usage
Description
(4-(4-methoxybenzyloxy)-3-nitrophenyl)methanol is a chemical compound that features a 3-nitrophenyl group connected to a methanol molecule through a benzyl ether linkage. The incorporation of a methoxy group on the benzyl ether and a nitro group on the phenyl ring endows the compound with distinctive properties and potential applications in various fields.
Used in Organic Synthesis:
(4-(4-methoxybenzyloxy)-3-nitrophenyl)methanol is used as an intermediate in organic synthesis for its unique structural features that can be further modified or utilized in the creation of more complex organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (4-(4-methoxybenzyloxy)-3-nitrophenyl)methanol is used as a research compound to explore its potential as a building block for the development of new drugs, given its specific functional groups and structural attributes.
Used as a Reagent in Chemical Reactions:
(4-(4-methoxybenzyloxy)-3-nitrophenyl)methanol serves as a reagent in various chemical reactions, taking advantage of its reactive nitro and methoxy groups to facilitate specific transformations or syntheses.
Check Digit Verification of cas no
The CAS Registry Mumber 942215-76-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,2,2,1 and 5 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 942215-76:
(8*9)+(7*4)+(6*2)+(5*2)+(4*1)+(3*5)+(2*7)+(1*6)=161
161 % 10 = 1
So 942215-76-1 is a valid CAS Registry Number.
942215-76-1Relevant articles and documents
COMPOUNDS WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
-
Page/Page column 131, (2009/04/25)
Compounds of formula (I) or a salt thereof are provided: wherein R4, R5, R6, Q, A, Y and R are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments for treating psychotic disorders, cognitive impairments and Alzheimer's Disease are disclosed. The invention further discloses pharmaceutical compositions comprising the compounds.
